Just 51% of Americans Will Take First Generation COVID-19 Vaccine | Beaufort County Now | Three vaccines are now in the late stages of development | daily wire, coronavirus, covid-19, vaccine, first generation vaccine, november 24, 2020

Coronavirus Disease 2019 (COVID-19)

Just 51% of Americans Will Take First Generation COVID-19 Vaccine

Publisher's Note: This post appears here courtesy of the The Daily Wire. The author of this post is Joseph Curl.

    Just slightly more than half of Americans plan to take a COVID-19 vaccine immediately after one becomes available, according to a new poll.

    Fifty-one percent of those surveyed in new polling by Ipsos released Tuesday said they would rush out to take a first-generation vaccine. While the number is low, it's up 6 points from the previous week and a 14-point increase from late September.

    Americans are also optimistic that a vaccine will be developed and approved soon.

    "Perhaps signaling that a vaccine is now more tangible and less aspirational, nearly half (47%) believe the vaccine will be ready within the next three months, up 15 percentage points from just one week ago," the poll found.

    In another finding, some 70% said they would get a vaccine if it draws the endorsement of public health officials. "Among some groups who are less likely to get a vaccine, namely Black Americans and Republicans, majorities report they would get a vaccine backed by public health officials," the pollsters wrote.

    Pollsters surveyed 1,002 adults from Nov. 20-23 and the poll has a margin of error of plus or minus 3% to 3.4%.

    There are currently three vaccines in the late stages of development.

    AstraZeneca and Oxford University on Monday said their jointly created COVID-19 vaccine has proven to be up to 90% effective and easier to distribute than another potential vaccine, which must be kept at sub-zero temperatures.

    "These findings show that we have an effective vaccine that will save many lives," said Oxford University professor Andrew Pollard, who served as the lead investigator for the drug's trials. "Because the vaccine can be stored at fridge temperatures, it can be distributed around the world using the normal immunization distribution system. And so our goal ... to make sure that we have a vaccine that was accessible everywhere, I think we've actually managed to do that."

    A new Moderna vaccine that was developed in conjunction with the Trump administration's Operation Warp Speed is nearly 95% effective, the company announced last week.

    "The analysis evaluated 95 confirmed Covid-19 infections among the trial's 30,000 participants," CNBC reported earlier this month. "Moderna, which developed its vaccine in collaboration with the National Institute of Allergy and Infectious Diseases, said 90 cases of Covid-19 were observed in the placebo group versus 5 cases observed in the group that received its two-dose vaccine. That resulted in an estimated vaccine efficacy of 94.5%."

    And the pharmaceutical company Pfizer said on Nov. 9 that its developmental vaccine for COVID-19 may be 90% effective at inoculating people against the disease. Pfizer CEO Albert Bourla said at the time that once their vaccine is approved by the Food and Drug Administration (FDA), it will be shipped quickly to locations in the U.S.

    But CNBC penned a story on Monday headline: "Doctors say CDC should warn people the side effects from Covid vaccine shots won't be 'a walk in the park.'"

    "Participants in Moderna and Pfizer's coronavirus vaccine trials told CNBC in September that they were experiencing high fever, body aches, bad headaches, daylong exhaustion and other symptoms after receiving the shots," the network reported. "While the symptoms were uncomfortable, and at times intense, the participants said they often went away after a day, sometimes sooner, and that it was better than getting Covid-19."


Latest Op-Ed & Politics

Vice President Mike Pence reportedly called Vice-President Elect Kamala Harris on Thursday to congratulate her on her win.
Many of us are very frustrated with the present political situation in both North Carolina and the Washington, D. C.
Gov. Roy Cooper is again pushing for a multibillion-dollar infrastructure bond, but Republican leaders caution that North Carolina’s still-unsteady economy makes it impossible to tell whether it would be prudent.
Order to release information within 180 days was part of $2.3 trillion COVID-19 relief bill
Clarice Feldman of the American Thinker explores the political calculations linked to President Trump’s second impeachment.


Governor Roy Cooper announced today that the North Carolina Executive Mansion will be illuminated on January 19, 2021, at 5:30 PM in remembrance of the lives lost as in the COVID-19 pandemic.
In her fine opinion piece for the Martin Center, Megan Zogby bemoans the “Quixotic” requirement that North Carolina college and university students take between two and four courses in a language such as Spanish, French, or German.
In this installment, we will discuss the "controversial" Gospel of Judas and how it can be used to decipher cryptic messages made by actors portraying the role of "Judas" in the current political arena..
Frank Main and Fran Spielman write in the Chicago Sun-Times about one consequence of the recent nationwide attack on police.
West Virginia leads the nation in COVID-19 vaccine administration and distribution, even more so than other states that have gained attention for their vaccine rollout strategies, according to federal data from the Centers for Disease Control and Prevention.
Bill Moore looks at the Democrats call for unity


He denounced the assault on the Capitol. But still the Democrats want his head.


Back to Top